別 名
PA1B2_HUMAN; PAF acetylhydrolase 30 kDa subunit; PAF
AH 30 kDa subunit; PAF AH beta subunit; PAF AH subunit beta; PAF-AH 30 kDa
subunit; PAF-AH subunit beta; PAFAH 30 kDa subunit; PAFAH beta subunit; PAFAH
subunit beta; Pafah1b2; PAFAH1B2 protein; PAFAHB; Platelet activating factor
acetylhydrolase IB beta subunit; Platelet activating factor acetylhydrolase IB
subunit beta; Platelet activating factor acetylhydrolase isoform Ib beta
subunit; Platelet-activating factor acetylhydrolase IB subunit beta.
交叉反應(yīng);Rat, (predicted: Human, Mouse, Horse, Sheep, )
產(chǎn)品應(yīng)用;WB=1:500-2000
ELISA=1:5000-10000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:50-200 (石蠟切片需做抗原修復(fù))
not yet tested in
other applications.
optimal
dilutions/concentrations should be determined by the end user.
免 疫 原;KLH conjugated synthetic
peptide derived from human PAFAH1B2: 101-200/229
亞 型;IgG
純化方法;affinity purified by Protein A
保存條件;Shipped at 4℃. Store at -20 °C for one year. Avoid
repeated freeze/thaw cycles.
注意事項;This product as supplied is
intended for research use only, not for use in human, therapeutic or diagnostic
applications.
血小板衍化生長因子β抗體產(chǎn)品介紹:
Inactivates PAF by
removing the acetyl group at the sn-2position. This is a catalytic subunit.
|